 | • レポートコード：QYR9ST00444 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の糖尿病薬物療法市場について調査・分析し、以下の構成でお届け致します。糖尿病薬物療法の種類別には、グルカゴン様ペプチド-1（GLP-1）アゴニスト、ジペプチジルペプチダーゼ-4（DPP-4）阻害剤、ナトリウムグルコース共輸送体2（SGLT2）阻害剤、インスリン、その他に、用途別には、1型糖尿病、2型糖尿病、妊娠糖尿病、耐糖能異常および空腹時血糖障害に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別糖尿病薬物療法売上データ ・地域別糖尿病薬物療法市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別糖尿病薬物療法市場規模：グルカゴン様ペプチド-1（GLP-1）アゴニスト、ジペプチジルペプチダーゼ-4（DPP-4）阻害剤、ナトリウムグルコース共輸送体2（SGLT2）阻害剤、インスリン、その他 ・用途別糖尿病薬物療法市場規模：1型糖尿病、2型糖尿病、妊娠糖尿病、耐糖能異常および空腹時血糖障害 ・主要メーカーの企業情報：Abbott Laboratories、Mannkind Corporation、Bristol Myers Squibb、Medtronic、AstraZeneca、Eli Lilly and Company、GlaxoSmithKline、Sanofi、Novo Nordisk、Novartis International AG ・糖尿病薬物療法の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.The global Diabetes Drug Therapy market is valued at 10000 million US$ in 2018 and will reach 21400 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Diabetes Drug Therapy market based on company, product type, end user and key regions.
This report studies the global market size of Diabetes Drug Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diabetes Drug Therapy in these regions.
This research report categorizes the global Diabetes Drug Therapy market by top players/brands, region, type and end user. This report also studies the global Diabetes Drug Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
Mannkind Corporation
Bristol Myers Squibb
Medtronic
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Novo Nordisk
Novartis International AG
Market size by Product
Glucagon-like peptide-1 (GLP-1) agonist
Dipeptidyl-peptidase-4 (DPP-4) inhibitors
Sodium glucose co-transporter 2 (SGLT2) inhibitors
Insulin
Others
Market size by End User
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Impaired Glucose Tolerance and Impaired Fasting Glycaemia
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Diabetes Drug Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Diabetes Drug Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Diabetes Drug Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Diabetes Drug Therapy submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Diabetes Drug Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diabetes Drug Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Diabetes Drug Therapy Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Diabetes Drug Therapy Market Size Growth Rate by Product
1.4.2 Glucagon-like peptide-1 (GLP-1) agonist
1.4.3 Dipeptidyl-peptidase-4 (DPP-4) inhibitors
1.4.4 Sodium glucose co-transporter 2 (SGLT2) inhibitors
1.4.5 Insulin
1.4.6 Others
1.5 Market by End User
1.5.1 Global Diabetes Drug Therapy Market Size Growth Rate by End User
1.5.2 Type 1 Diabetes
1.5.3 Type 2 Diabetes
1.5.4 Gestational Diabetes
1.5.5 Impaired Glucose Tolerance and Impaired Fasting Glycaemia
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Diabetes Drug Therapy Market Size
2.1.1 Global Diabetes Drug Therapy Revenue 2014-2025
2.1.2 Global Diabetes Drug Therapy Sales 2014-2025
2.2 Diabetes Drug Therapy Growth Rate by Regions
2.2.1 Global Diabetes Drug Therapy Sales by Regions
2.2.2 Global Diabetes Drug Therapy Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Diabetes Drug Therapy Sales by Manufacturers
3.1.1 Diabetes Drug Therapy Sales by Manufacturers
3.1.2 Diabetes Drug Therapy Sales Market Share by Manufacturers
3.1.3 Global Diabetes Drug Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Diabetes Drug Therapy Revenue by Manufacturers
3.2.1 Diabetes Drug Therapy Revenue by Manufacturers (2014-2019)
3.2.2 Diabetes Drug Therapy Revenue Share by Manufacturers (2014-2019)
3.3 Diabetes Drug Therapy Price by Manufacturers
3.4 Diabetes Drug Therapy Manufacturing Base Distribution, Product Types
3.4.1 Diabetes Drug Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diabetes Drug Therapy Product Type
3.4.3 Date of International Manufacturers Enter into Diabetes Drug Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Diabetes Drug Therapy Sales by Product
4.2 Global Diabetes Drug Therapy Revenue by Product
4.3 Diabetes Drug Therapy Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Diabetes Drug Therapy Breakdown Data by End User
6 North America
6.1 North America Diabetes Drug Therapy by Countries
6.1.1 North America Diabetes Drug Therapy Sales by Countries
6.1.2 North America Diabetes Drug Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Diabetes Drug Therapy by Product
6.3 North America Diabetes Drug Therapy by End User
7 Europe
7.1 Europe Diabetes Drug Therapy by Countries
7.1.1 Europe Diabetes Drug Therapy Sales by Countries
7.1.2 Europe Diabetes Drug Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Diabetes Drug Therapy by Product
7.3 Europe Diabetes Drug Therapy by End User
8 Asia Pacific
8.1 Asia Pacific Diabetes Drug Therapy by Countries
8.1.1 Asia Pacific Diabetes Drug Therapy Sales by Countries
8.1.2 Asia Pacific Diabetes Drug Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Diabetes Drug Therapy by Product
8.3 Asia Pacific Diabetes Drug Therapy by End User
9 Central & South America
9.1 Central & South America Diabetes Drug Therapy by Countries
9.1.1 Central & South America Diabetes Drug Therapy Sales by Countries
9.1.2 Central & South America Diabetes Drug Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Diabetes Drug Therapy by Product
9.3 Central & South America Diabetes Drug Therapy by End User
10 Middle East and Africa
10.1 Middle East and Africa Diabetes Drug Therapy by Countries
10.1.1 Middle East and Africa Diabetes Drug Therapy Sales by Countries
10.1.2 Middle East and Africa Diabetes Drug Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Diabetes Drug Therapy by Product
10.3 Middle East and Africa Diabetes Drug Therapy by End User
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Laboratories Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott Laboratories Diabetes Drug Therapy Products Offered
11.1.5 Abbott Laboratories Recent Development
11.2 Mannkind Corporation
11.2.1 Mannkind Corporation Company Details
11.2.2 Company Business Overview
11.2.3 Mannkind Corporation Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Mannkind Corporation Diabetes Drug Therapy Products Offered
11.2.5 Mannkind Corporation Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Company Business Overview
11.3.3 Bristol Myers Squibb Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bristol Myers Squibb Diabetes Drug Therapy Products Offered
11.3.5 Bristol Myers Squibb Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Details
11.4.2 Company Business Overview
11.4.3 Medtronic Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Medtronic Diabetes Drug Therapy Products Offered
11.4.5 Medtronic Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Business Overview
11.5.3 AstraZeneca Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.5.4 AstraZeneca Diabetes Drug Therapy Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Company Business Overview
11.6.3 Eli Lilly and Company Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Eli Lilly and Company Diabetes Drug Therapy Products Offered
11.6.5 Eli Lilly and Company Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 Company Business Overview
11.7.3 GlaxoSmithKline Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.7.4 GlaxoSmithKline Diabetes Drug Therapy Products Offered
11.7.5 GlaxoSmithKline Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Company Business Overview
11.8.3 Sanofi Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Sanofi Diabetes Drug Therapy Products Offered
11.8.5 Sanofi Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Company Business Overview
11.9.3 Novo Nordisk Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Novo Nordisk Diabetes Drug Therapy Products Offered
11.9.5 Novo Nordisk Recent Development
11.10 Novartis International AG
11.10.1 Novartis International AG Company Details
11.10.2 Company Business Overview
11.10.3 Novartis International AG Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Novartis International AG Diabetes Drug Therapy Products Offered
11.10.5 Novartis International AG Recent Development
12 Future Forecast
12.1 Diabetes Drug Therapy Market Forecast by Regions
12.1.1 Global Diabetes Drug Therapy Sales Forecast by Regions 2019-2025
12.1.2 Global Diabetes Drug Therapy Revenue Forecast by Regions 2019-2025
12.2 Diabetes Drug Therapy Market Forecast by Product
12.2.1 Global Diabetes Drug Therapy Sales Forecast by Product 2019-2025
12.2.2 Global Diabetes Drug Therapy Revenue Forecast by Product 2019-2025
12.3 Diabetes Drug Therapy Market Forecast by End User
12.4 North America Diabetes Drug Therapy Forecast
12.5 Europe Diabetes Drug Therapy Forecast
12.6 Asia Pacific Diabetes Drug Therapy Forecast
12.7 Central & South America Diabetes Drug Therapy Forecast
12.8 Middle East and Africa Diabetes Drug Therapy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Diabetes Drug Therapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Diabetes Drug Therapy Product Picture
Table Diabetes Drug Therapy Market Segments
Table Key Manufacturers Diabetes Drug Therapy Covered
Table Global Diabetes Drug Therapy Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Diabetes Drug Therapy Sales Market Share by Product 2014-2025
Figure Glucagon-like peptide-1 (GLP-1) agonist Product Picture
Table Major Manufacturers of Glucagon-like peptide-1 (GLP-1) agonist
Figure Dipeptidyl-peptidase-4 (DPP-4) inhibitors Product Picture
Table Major Manufacturers of Dipeptidyl-peptidase-4 (DPP-4) inhibitors
Figure Sodium glucose co-transporter 2 (SGLT2) inhibitors Product Picture
Table Major Manufacturers of Sodium glucose co-transporter 2 (SGLT2) inhibitors
Figure Insulin Product Picture
Table Major Manufacturers of Insulin
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Diabetes Drug Therapy Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Type 1 Diabetes
Figure Type 2 Diabetes
Figure Gestational Diabetes
Figure Impaired Glucose Tolerance and Impaired Fasting Glycaemia
Figure Diabetes Drug Therapy Report Years Considered
Figure Global Diabetes Drug Therapy Market Size 2014-2025 (Million US$)
Figure Global Diabetes Drug Therapy Sales 2014-2025 (K Units)
Table Global Diabetes Drug Therapy Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Diabetes Drug Therapy Sales by Regions 2014-2019 (K Units)
Table Global Diabetes Drug Therapy Sales Market Share by Regions 2014-2019
Figure Global Diabetes Drug Therapy Sales Market Share by Regions 2014-2019
Figure 2018 Global Diabetes Drug Therapy Sales Market Share by Regions
Table Global Diabetes Drug Therapy Revenue by Regions 2014-2019 (Million US$)
Table Global Diabetes Drug Therapy Revenue Market Share by Regions 2014-2019
Figure Global Diabetes Drug Therapy Revenue Market Share by Regions 2014-2019
Figure 2018 Global Diabetes Drug Therapy Revenue Market Share by Regions
Table Global Diabetes Drug Therapy Sales by Manufacturers (2014-2019) (K Units)
Table Global Diabetes Drug Therapy Sales Share by Manufacturers (2014-2019)
Figure Global Diabetes Drug Therapy Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Diabetes Drug Therapy Revenue by Manufacturers (2014-2019) (Million USD)
Table Diabetes Drug Therapy Revenue Share by Manufacturers (2014-2019)
Figure Diabetes Drug Therapy Value Share by Manufacturers in 2018
Table Key Manufacturers Diabetes Drug Therapy Price (2014-2019) (USD/Unit)
Table Diabetes Drug Therapy Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Diabetes Drug Therapy Product Type
Table Date of International Manufacturers Enter into Diabetes Drug Therapy Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Diabetes Drug Therapy Sales by Product (2014-2019) (K Units)
Table Global Diabetes Drug Therapy Sales Share by Product (2014-2019)
Figure Global Diabetes Drug Therapy Sales Market Share by Product (2014-2019)
Figure Global Diabetes Drug Therapy Sales Market Share by Product in 2018
Table Global Diabetes Drug Therapy Revenue by Product (2014-2019) (Million US$)
Table Global Diabetes Drug Therapy Revenue Share by Product (2014-2019)
Figure Global Diabetes Drug Therapy Revenue Market Share by Product (2014-2019)
Figure Global Diabetes Drug Therapy Revenue Market Share by Product in 2018
Table Diabetes Drug Therapy Price by Product 2014-2019 (USD/Unit)
Table Global Diabetes Drug Therapy Sales by End User (2014-2019) (K Units)
Table Global Diabetes Drug Therapy Sales Share by End User (2014-2019)
Figure Global Sales Diabetes Drug Therapy Market Share by End User (2014-2019)
Figure Global Sales Diabetes Drug Therapy Market Share by End User in 2018
Figure North America Diabetes Drug Therapy Sales Growth Rate 2014-2019 (K Units)
Figure North America Diabetes Drug Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table North America Diabetes Drug Therapy Sales by Countries (2014-2019) (K Units)
Table North America Diabetes Drug Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 North America Diabetes Drug Therapy Sales Market Share by Countries
Table North America Diabetes Drug Therapy Revenue by Countries (2014-2019) (Million US$)
Table North America Diabetes Drug Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Diabetes Drug Therapy Revenue Market Share by Countries
Figure United States Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure United States Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Canada Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table North America Diabetes Drug Therapy Sales by Product (2014-2019) (K Units)
Table North America Diabetes Drug Therapy Sales Market Share by Product (2014-2019)
Figure 2018 North America Diabetes Drug Therapy Market Share by Product
Table North America Diabetes Drug Therapy Sales by End User (2014-2019) (K Units)
Table North America Diabetes Drug Therapy Sales Market Share by End User (2014-2019)
Figure 2018 North America Diabetes Drug Therapy Market Share by End User
Figure Europe Diabetes Drug Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Europe Diabetes Drug Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Diabetes Drug Therapy Sales by Countries (2014-2019) (K Units)
Table Europe Diabetes Drug Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Diabetes Drug Therapy Sales Market Share by Countries
Table Europe Diabetes Drug Therapy Revenue by Countries (2014-2019) (Million US$)
Table Europe Diabetes Drug Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Diabetes Drug Therapy Revenue Market Share by Countries
Figure Germany Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Germany Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure France Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure France Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure UK Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Italy Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Russia Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Diabetes Drug Therapy Sales by Product (2014-2019) (K Units)
Table Europe Diabetes Drug Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Europe Diabetes Drug Therapy Market Share by Product
Table Europe Diabetes Drug Therapy Sales by End User (2014-2019) (K Units)
Table Europe Diabetes Drug Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Europe Diabetes Drug Therapy Market Share by End User
Figure Asia Pacific Diabetes Drug Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Diabetes Drug Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Diabetes Drug Therapy Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Diabetes Drug Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Diabetes Drug Therapy Sales Market Share by Countries
Table Asia Pacific Diabetes Drug Therapy Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Diabetes Drug Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Diabetes Drug Therapy Revenue Market Share by Countries
Figure China Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure China Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Japan Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Korea Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure India Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure India Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Australia Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Diabetes Drug Therapy Sales by Product (2014-2019) (K Units)
Table Asia Pacific Diabetes Drug Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Diabetes Drug Therapy Market Share by Product
Table Asia Pacific Diabetes Drug Therapy Sales by End User (2014-2019) (K Units)
Table Asia Pacific Diabetes Drug Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Diabetes Drug Therapy Market Share by End User
Figure Central & South America Diabetes Drug Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Diabetes Drug Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Diabetes Drug Therapy Sales by Countries (2014-2019) (K Units)
Table Central & South America Diabetes Drug Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Diabetes Drug Therapy Sales Market Share by Countries
Table Central & South America Diabetes Drug Therapy Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Diabetes Drug Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Diabetes Drug Therapy Revenue Market Share by Countries
Figure Brazil Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Diabetes Drug Therapy Sales by Product (2014-2019) (K Units)
Table Central & South America Diabetes Drug Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Diabetes Drug Therapy Market Share by Product
Table Central & South America Diabetes Drug Therapy Sales by End User (2014-2019) (K Units)
Table Central & South America Diabetes Drug Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Diabetes Drug Therapy Market Share by End User
Figure Middle East and Africa Diabetes Drug Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Diabetes Drug Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Diabetes Drug Therapy Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Diabetes Drug Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Diabetes Drug Therapy Sales Market Share by Countries
Table Middle East and Africa Diabetes Drug Therapy Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Diabetes Drug Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Diabetes Drug Therapy Revenue Market Share by Countries
Figure GCC Countries Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Diabetes Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Diabetes Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Diabetes Drug Therapy Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Diabetes Drug Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Diabetes Drug Therapy Market Share by Product
Table Middle East and Africa Diabetes Drug Therapy Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Diabetes Drug Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Diabetes Drug Therapy Market Share by End User
Table Abbott Laboratories Company Details
Table Abbott Laboratories Diabetes Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table Mannkind Corporation Company Details
Table Mannkind Corporation Diabetes Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mannkind Corporation Recent Development
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Diabetes Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol Myers Squibb Recent Development
Table Medtronic Company Details
Table Medtronic Diabetes Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Medtronic Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Diabetes Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Diabetes Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly and Company Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Diabetes Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sanofi Company Details
Table Sanofi Diabetes Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Diabetes Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novo Nordisk Recent Development
Table Novartis International AG Company Details
Table Novartis International AG Diabetes Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis International AG Recent Development
Table Global Diabetes Drug Therapy Sales Forecast by Regions 2019-2025 (K Units)
Table Global Diabetes Drug Therapy Sales Market Share Forecast by Regions 2019-2025
Table Global Diabetes Drug Therapy Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Diabetes Drug Therapy Revenue Market Share Forecast by Regions 2019-2025
Table Global Diabetes Drug Therapy Sales Forecast by Product 2019-2025 (K Units)
Table Global Diabetes Drug Therapy Sales Market Share Forecast by Product 2019-2025
Table Global Diabetes Drug Therapy Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Diabetes Drug Therapy Revenue Market Share Forecast by Product 2019-2025
Table Global Diabetes Drug Therapy Sales Forecast by End User 2019-2025 (K Units)
Table Global Diabetes Drug Therapy Sales Market Share Forecast by End User 2019-2025
Figure North America Diabetes Drug Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Diabetes Drug Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Diabetes Drug Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Diabetes Drug Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Diabetes Drug Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Diabetes Drug Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Diabetes Drug Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Diabetes Drug Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Diabetes Drug Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Diabetes Drug Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Diabetes Drug Therapy Value Chain
Table Diabetes Drug Therapy Customers List
Table Diabetes Drug Therapy Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
次世代の糖尿病治療及びドラッグデリバリーの世界市場：市場規模・現状・予測 Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.The market growth is attributed to the rise in the number of diabetic patients globally a…- 糖尿病及び関連疾患向け幹細胞療法の世界市場：市場規模・現状・予測 Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).NSI-566 is the stem cell therap…
- 糖尿病及び関連疾患向け幹細胞療法の世界市場：市場規模・現状・予測 Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).NSI-566 is the stem cell therap…
- 非インスリン糖尿病治療薬の世界市場：市場規模・現状・予測 Non-insulin diabetes therapeutics are mostly administered orally and prescribed when diet and exercise are insufficient to control elevated blood glucose levels.In 2018, the global Non-insulin Diabetes Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end …
- 2型糖尿病の世界市場：インサイト・予測 Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk fact…